| BNTX Stock | | | USD 108.23 6.09 5.96% |
BioNTech financial indicator trend analysis is way more than just evaluating BioNTech SE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioNTech SE is a good investment. Please check the relationship between BioNTech Total Current Liabilities and its Cash And Short Term Investments accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Total Current Liabilities vs Cash And Short Term Investments
Total Current Liabilities vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
BioNTech SE Total Current Liabilities account and
Cash And Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between BioNTech's Total Current Liabilities and Cash And Short Term Investments is 0.63. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of BioNTech SE, assuming nothing else is changed. The correlation between historical values of BioNTech's Total Current Liabilities and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of BioNTech SE are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Current Liabilities i.e., BioNTech's Total Current Liabilities and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.63 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Current Liabilities
Total Current Liabilities is an item on BioNTech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of BioNTech SE are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of BioNTech SE balance sheet. This account contains BioNTech investments that will expire within one year. These investments include stocks and bonds that can be liquidated by BioNTech SE fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from BioNTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioNTech SE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
At this time, BioNTech's
Selling General Administrative is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to rise to 0.21 in 2024, whereas
Tax Provision is likely to drop slightly above 243
M in 2024.
BioNTech fundamental ratios Correlations
Click cells to compare fundamentals
BioNTech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BioNTech fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to
measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to
predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.